Medtronic’s potential rivalry in US market Medtronic’s Hugo robot poses the main challenge to da Vinci given the company's size. Hugo has been in use in Europe since 2022 and the company ...

Medtronic is nearing a U.S. launch for its Hugo surgical robot more than three years after receiving approval to release the soft tissue system in Europe. CEO Geoff Martha told investors Tuesday ...

It offers leading health care solutions to challenging problems, such as robotic-assisted surgeries through Medtronic Hugo. These robots and Medtronic's other AI investments can reduce human ...

Medtronic’s Hugo™ robotic-assisted surgery system is modular and portable for flexibility and efficiency across surgeries. Our team redesigned the Sterile Interface Module, which separates Hugo’s arm ...

Discover why Intuitive Surgical's monopoly-like position is under threat from emerging competitors like Medtronic and J&J.

In MedSurg, despite all distributor disruptions, Medtronic is scaling the production of Hugo RAS. The Neuroscience portfolios continue to contribute. Further, the company’s Pacing business ...

Recent gains from Medtronic (MDT -7%) are being cut into today despite the ... MDT noted that utilization is continuing to increase overseas, with Hugo procedure volumes doubling yr/yr. Hugo is MDT's ...

2. Renal denervation: Medtronic is awaiting CMS approval for this innovative treatment, which could open up new revenue streams in the hypertension market. 3. Hugo surgical robot: The company’s ...

Medtronic reported 4.1% organic revenue growth and 6.2% adjusted EPS growth. See why we upgraded MDT stock to 'Buy' with a ...